BioSyent Inc. (OTC:BIOYF)

Sunday, June 2, 2024, 2:22 PM
Reflection On TSSI 620% Return [GeoWire Weekly No. 138]
Sunday, May 26, 2024, 4:30 PM
Another Well-Deserved Hat Tip To Our Contributors [GeoWire Weekly No. 137]
See All GeoWire Weekly...
BioSyent is a profitable growth oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty, and international business units. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn and Tibella.

Last updated May 20, 2024


Market Data powered by QuoteMedia. Terms of Use